Accordingly, genetic risk variants identified as ancestry-specific signals through fine mapping of causal variants (AGMO-rs73284431, VT11A-rs17746147, and ZRANB3), and the transferable genetic risk variants (TCF7L2), are reported to act through beta-cell dysfunction to confer the risk of T2DM [36, 37]. This evidence concerns the gene AGMO and type 2 diabetes mellitus.